EcoDrugPlus

Telomerase Reverse Transcriptase

Ensembl ID : ENSLCAG00010024920
Gene Symbol: LOC108900386
4 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSLCAG00010019957
Gene Symbol: TBXAS1
1 Cross references
217 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSLCAG00010020857
Gene Symbol: TBXAS1
1 Cross references
217 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSLCAG00010014318
Gene Symbol: TBXAS1
1 Cross references
217 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSLCAG00010009684
Gene Symbol: TBXA2R
1 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSLCAG00010008622
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSLCAG00010005209
Gene Symbol: TYMS
1 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSLCAG00010002996
Gene Symbol: LOC108900268
4 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSLCAG00010016058
Gene Symbol: TRHR
4 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSLCAG00010013758
Gene Symbol: LOC108899094
4 Cross references
193 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSLCAG00010019362
Gene Symbol: TLR2
2 Cross references
183 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSLCAG00010006335
Gene Symbol: TLR7
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).